However, it is largely unknown whether nonalcoholic fatty liver disease (NAFLD), a condition associated with both diabetes and FGF-21 levels [9], may explain or modify the association between FGF-21 and diabetes risk. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.